$72.09
0.32% yesterday
NYSE, Aug 12, 10:00 pm CET
ISIN
US83444M1018
Symbol
SOLV

Solventum Stock price

$72.09
-1.98 2.67% 1M
-1.59 2.16% 6M
+6.03 9.13% YTD
+14.38 24.92% 1Y
-7.91 9.89% 3Y
-7.91 9.89% 5Y
-7.91 9.89% 10Y
-7.91 9.89% 20Y
NYSE, Closing price Tue, Aug 12 2025
+0.23 0.32%
ISIN
US83444M1018
Symbol
SOLV
Index

Key metrics

Basic
Market capitalization
$12.4b
Enterprise Value
$19.8b
Net debt
$7.3b
Cash
$492.0m
Shares outstanding
173.4m
Valuation (TTM | estimate)
P/E
33.0 | 12.6
P/S
1.5 | 1.4
EV/Sales
2.4 | 2.3
EV/FCF
134.4
P/B
3.4
Financial Health
Equity Ratio
20.5%
Return on Equity
16.2%
ROCE
6.2%
ROIC
7.7%
Debt/Equity
2.1
Financials (TTM | estimate)
Revenue
$8.4b | $8.6b
EBITDA
$1.3b | $2.0b
EBIT
$777.0m | $1.7b
Net Income
$380.0m | $986.3m
Free Cash Flow
$147.0m
Growth (TTM | estimate)
Revenue
2.2% | 4.1%
EBITDA
-37.3% | 23.6%
EBIT
-49.4% | 56.8%
Net Income
-64.1% | 105.9%
Free Cash Flow
-90.4%
Margin (TTM | estimate)
Gross
54.6%
EBITDA
15.6% | 23.8%
EBIT
9.3%
Net
4.5% | 11.5%
Free Cash Flow
1.8%
More
EPS
$2.2
FCF per Share
$0.8
Short interest
2.8%
Employees
-
Rev per Employee
-
Show more

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Solventum forecast:

10x Buy
53%
8x Hold
42%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Solventum forecast:

Buy
53%
Hold
42%
Sell
5%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8,388 8,388
2% 2%
100%
- Direct Costs 3,805 3,805
8% 8%
45%
4,583 4,583
2% 2%
55%
- Selling and Administrative Expenses 3,021 3,021
27% 27%
36%
- Research and Development Expense 760 760
0% 0%
9%
1,311 1,311
37% 37%
16%
- Depreciation and Amortization 534 534
4% 4%
6%
EBIT (Operating Income) EBIT 777 777
49% 49%
9%
Net Profit 380 380
64% 64%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Neutral
Seeking Alpha
5 days ago
Solventum Corporation (NYSE:SOLV ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan C. Hanson - CEO & Director Wayde D.
Positive
The Motley Fool
5 days ago
Solventum (SOLV) Fiscal Q2 EPS Jumps 8%
Positive
Reuters
5 days ago
Medical device maker Solventum raised full-year adjusted profit forecast on Thursday, driven by strong sales of its wound care and surgical sterilization products alongside lower expenses.
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Website www.solventum.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today